药物短缺:临床影响和负担 - - 一项跨国多方法研究,包括关键利益相关者
Olaf Rose1,2, Kreshnik Hoti3, Blete Isufi3
1Institute of Pharmacy, Pharmaceutical Biology and Clinical Pharmacy, Paracelsus Medical University Salzburg, Salzburg, Austria.
Journal of pharmaceutical policy and practice
|September 26, 2025
概括
药品短缺严重扰乱了奥地利,德国和科索沃的患者护理,影响了药剂师和医生. 除了监管障碍之外,政治和经济因素推动了这一危机,需要协调解决药物可用性的解决方案.
科学领域:
- 药理学 药理学是指药理学的学科.
- 医疗保健服务研究 医疗服务研究
- 公共卫生 公共卫生
背景情况:
- 近年来,药物短缺的蔓延越来越大.
- 在奥地利,德国和科索沃的医疗保健系统中存在显著差异.
- 需要调查药物短缺在各种医疗保健机构的临床影响和负担.
研究的目的:
- 调查药物短缺的临床影响和负担.
- 为了比较三个不同医疗保健系统的国家的这些影响.
- 确定药物短缺的根本原因和促成因素.
主要方法:
- 三国,多种方法的研究设计.
- 使用问卷和深入访谈与患者,医生,药剂师和制造商.
- 采用了定量数据的描述性统计数据和Mayring定性数据的定性内容分析.
主要成果:
- 制造商面临着定价压力和通货膨胀;缓解策略可能会增加成本.
- 药剂师和医生报告了严重的实践中断,多达50%的患者接触受到影响.
- 患者经历了中等程度的治疗中断;政治因素被确定为主要的根本原因.
结论:
- 药物短缺严重扰乱了研究国家的临床实践和患者护理.
- 经济压力,政治因素和监管障碍加剧了药物短缺危机.
- 协调的缓解策略对于解决确定的原因和改善药物可用性至关重要.
相关概念视频
Drug Control Governance: Regulatory Bodies and Their Impact
495
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
495
Measurement of Bioavailability: Pharmacodynamic Methods
236
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
236
Bioavailability Study Design: Single Versus Multiple Dose Studies
210
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
210
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
407
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
407
Therapeutic Drug Monitoring: Drug Analysis Methods
179
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
179
Therapeutic Drug Monitoring: Affecting Factors
201
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
201


